Wednesday, July 8, 2026

Drug profile · INN

air

air (AIR) is an FDA-listed pharmaceutical active ingredient. Route of administration: inhalation. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 3
News articles 0
Drug details — air
US status
approved
Class
Route
INHALATION
Patents
0
Programs
3
Data quality
0.84

Quick answer

air (AIR) is an FDA-listed pharmaceutical active ingredient. Route of administration: inhalation. Current US regulatory status: approved.

Key facts

INN air
Brand AIR
Route INHALATION
Formulation GAS

Approval history

Authority Status Date
FDA approved

Pipeline programs

  1. AIR DNase™ Phase 2 · Protalix Biotherapeutics · Cystic Fibrosis
  2. Air médical en bouteille, OXYGEN Phase 2 · PARItec · Alternating Hemiplegia of Childhood
  3. AIR DNase Phase 1 · Protalix Biotherapeutics · Cystic Fibrosis (CF)

Frequently asked questions

What is air?

air (AIR) is an FDA-listed pharmaceutical active ingredient. Route of administration: inhalation. Current US regulatory status: approved.

What is the brand name for air?

AIR is a marketed brand name for air. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of air?

air has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.